- NKF •
- 7 May, 2026 •
- •
Nanoencapsulated Sirolimus Plus Pegadricase (NASP) Provides a Sustained 48-Week Response, Reducing Serum Uric Acid and Preserving Renal Function in Patients With Uncontrolled Gout (UG) and Stage 3 Chronic Kidney Disease
Nissreen Elfadawy, Rehan Azeem, Pirooz Parsa, Ben Peace, Yasir A. Qazi
Available materials